Expert Opinion on Therapeutic Patents, Volume 29, Issue 5 (2019)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 29, Issue 5 (2019)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Volume 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Patent Evaluation

Article
Treatment of cancer with a combination of LAG-3Ig and anti-PD-1/anti-PD-L1 antibodies: a patent evaluation of US2018271940 A1
Martin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada & Irma Herrera-Camacho
Pages: 311-314
Published online: 24 Apr 2019
AbstractforTreatment of cancer with a combination of LAG-3Ig and anti-PD-1/anti-PD-L1 antibodies: a patent evaluation of US2018271940 A1 | Full Text | References | PDF (641.2 KB) | EPUB
  • 159 Views
  • 5 CrossRef citations
  • 0Altmetric

Review

Article
A patent review of bisphosphonates in treating bone disease
Sarah A. Holstein
Pages: 315-325
Published online: 25 Apr 2019
AbstractforA patent review of bisphosphonates in treating bone disease | Full Text | References | PDF (1.5 MB) | EPUB
  • 308 Views
  • 18 CrossRef citations
  • 0Altmetric
Review
Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa
Mariel Dourado Alcorte, Mari Cleide Sogayar & Marcos Angelo Demasi
Pages: 327-337
Published online: 24 Apr 2019
AbstractforPatent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa | Full Text | References | PDF (1.2 MB) | EPUB
  • 326 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Effects of boron-containing compounds on immune responses: review and patenting trends
Karla S. Romero-Aguilar, Ivonne M. Arciniega-Martínez, Eunice D. Farfán-García, Rafael Campos-Rodríguez, Aldo A. Reséndiz-Albor & Marvin A. Soriano-Ursúa
Pages: 339-351
Published online: 07 May 2019
AbstractforEffects of boron-containing compounds on immune responses: review and patenting trends | Full Text | References | PDF (1.9 MB) | EPUB
  • 422 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
MYC modulators in cancer: a patent review
Xiao-Na Wang, Xiao-Xuan Su, Sui-Qi Cheng, Zhi-Yin Sun, Zhi-Shu Huang & Tian-Miao Ou
Pages: 353-367
Published online: 08 May 2019
AbstractforMYC modulators in cancer: a patent review | Full Text | References | PDF (1.8 MB) | EPUB
  • 950 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
SGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018)
Jyotsana Pandey & Akhilesh K Tamrakar
Pages: 369-384
Published online: 04 May 2019
AbstractforSGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018) | Full Text | References | PDF (2.1 MB) | EPUB
  • 539 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
An updated patent review of therapeutic applications of chalcone derivatives (2014-present)
Debarshi Kar Mahapatra, Vivek Asati & Sanjay Kumar Bharti
Pages: 385-406
Published online: 08 May 2019
AbstractforAn updated patent review of therapeutic applications of chalcone derivatives (2014-present) | Full Text | References | PDF (2 MB) | EPUB
  • 169 Views
  • 31 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Therapeutic potential of boswellic acids: an update patent review (2016–2023)
Hidayat Hussain et al.
Review Article | Published online: 5 Jul 2024
Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)
Mohammad Mahboubi-Rabbani et al.
Review Article | Published online: 3 Jul 2024
FAK inhibitors in cancer, a patent review – an update on progress
Ya-Xi Ye et al.
Review Article | Published online: 2 Jul 2024
Patent review of cannabinoid receptor type 2 (CB2R) modulators (2016-present)
Miroslav Kosar et al.
Review Article | Published online: 2 Jul 2024
View all latest articles